Stockscreener 앱 받기
2.92
5.04%
0.14
시간 외 거래:
2.90
-0.02
-0.68%
전일 마감가:
$2.78
열려 있는:
$2.78
하루 거래량:
1.65M
Relative Volume:
1.03
시가총액:
$828.44M
수익:
-
순이익/손실:
$-125.04M
주가수익비율:
-3.561
EPS:
-0.82
순현금흐름:
$-122.99M
1주 성능:
+13.18%
1개월 성능:
+22.69%
6개월 성능:
+139.34%
1년 성능:
+12.31%
1일 변동 폭
$2.751
$3.00
1주일 범위
$2.52
$3.075
52주 변동 폭
$1.01
$3.30
Erasca Inc Stock (ERAS) Company Profile
명칭
Erasca Inc
전화
(858) 465-6511
주소
3115 MERRYFIELD ROW, SAN DIEGO
ERAS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ERAS
Erasca Inc
|
2.92 | 788.72M | 0 | -125.04M | -122.99M | -0.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Erasca Inc Stock (ERAS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-16 | 개시 | Stifel | Buy |
| 2025-09-03 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2025-08-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-26 | 개시 | Raymond James | Outperform |
| 2024-11-18 | 개시 | Jefferies | Buy |
| 2024-03-11 | 개시 | CapitalOne | Overweight |
| 2024-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-10-11 | 개시 | H.C. Wainwright | Buy |
| 2023-03-30 | 개시 | Mizuho | Buy |
| 2023-02-24 | 개시 | Goldman | Buy |
| 2023-02-03 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
모두보기
Erasca Inc 주식(ERAS)의 최신 뉴스
Understanding Erasca Inc.’s price movementPortfolio Risk Summary & High Yield Equity Trading Tips - newser.com
Will Erasca Inc. stock benefit from automation2025 Earnings Surprises & Real-Time Volume Trigger Notifications - newser.com
Erasca Inc. stock chart pattern explainedJuly 2025 Market Mood & Safe Swing Trade Setups - newser.com
Why Erasca Inc. stock remains on watchlistsWeekly Stock Analysis & Free Weekly Watchlist of Top Performers - newser.com
Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B - GlobeNewswire
ErascaTargeting Cancer's Most Commonly Mutated Pathway - RTTNews
Analyzing Precision BioSciences (NASDAQ:DTIL) and Erasca (NASDAQ:ERAS) - Defense World
HC Wainwright Issues Optimistic Estimate for Erasca Earnings - Defense World
Heatmap analysis for Erasca Inc. and competitorsEarnings Overview Summary & Short-Term Swing Trade Alerts - newser.com
Analyzing net buyer seller activity in Erasca Inc.July 2025 Gainers & Free Growth Oriented Trading Recommendations - newser.com
Using fundamentals and technicals on Erasca Inc.IPO Watch & Risk Managed Investment Signals - newser.com
HC Wainwright Comments on Erasca’s Q1 Earnings (NASDAQ:ERAS) - Defense World
Why Erasca Inc. stock could see breakout soonTrade Performance Summary & AI Optimized Trade Strategies - newser.com
Is Erasca Inc. stock poised for growthQuarterly Growth Report & Weekly Top Performers Watchlists - newser.com
Erasca, Inc. Reports Q3 2025 Financial Results - MSN
Guggenheim raises Erasca stock price target to $5 on pipeline progress By Investing.com - Investing.com South Africa
Brokerages Set Erasca, Inc. (NASDAQ:ERAS) Price Target at $4.00 - Defense World
Erasca, Inc. (ERAS) stock price, news, quote and history - Yahoo Finance UK
Will Erasca Inc. stock maintain growth storyWeekly Volume Report & Daily Profit Focused Screening - newser.com
Analyzing drawdowns of Erasca Inc. with statistical tools2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - newser.com
Guggenheim Maintains Erasca (ERAS) Buy Recommendation - Nasdaq
Guggenheim raises Erasca stock price target to $5 on pipeline progress - Investing.com Australia
Erasca price target raised to $5 from $3 at Guggenheim - TipRanks
How to forecast Erasca Inc. trends using time seriesJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - newser.com
What analysts say about Erasca Inc stockShort Selling Opportunities & Identify Winning Stocks - earlytimes.in
Stifel reiterates Buy rating on Erasca stock, maintains $6 price target - Investing.com Canada
Erasca reports Q3 EPS (11c), consensus (10c) - MSN
Erasca Inc (ERAS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):